Competition & Peer Data API & CSV Delivery

Sunlink Health Systems Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Sunlink Health Systems Inc (SSY) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2025
Competitors Tracked
10
Publicly traded peers
Peer Group Market Share
0.02 %
vs 0.02 % a year ago
Revenue Growth Y/Y
-2.05 %
Peers: 2.43 %
Net Margin
-9.18 %
Peers: 8.41 %

Key Findings: Sunlink Health Systems Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 32M vs 157,624M combined for tracked competitors (0.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-8.0% annualized vs trailing 12 months), vs decelerating (-4.5%) for its tracked peer group.
  • Growth: Sunlink Health Systems Inc generated -2.1% revenue growth year over year in Q3 2025, vs 2.4% for its tracked competitors combined.
  • Profitability: Its -9.2% net margin compares with 8.4% for the peer group.
  • Peer revenue share: Sunlink Health Systems Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
  • Peer differentiation: Revenue per employee of $0.07M compares with $0.23M for the peer group (0.3x).

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

SSY Sales vs. its Competitors, Q3 2025

Sunlink Health Systems Inc reported revenue contraction of 2.05 % year on year in Q3 2025, below its competitors' combined revenue growth of 2.43 %.

With a net margin of -9.18 %, Sunlink Health Systems Inc reported lower profitability than its competitors (8.41 %).

Sunlink Health Systems Inc generated 0.02 % of the combined sales of its peer group, up from 0.02 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/SSY/competitors
https://api.csimarket.com/api/v1/companies/SSY/relationships
https://api.csimarket.com/api/v1/companies/SSY/similar
Programmatic access for models, analytics, and integration workflows.

Sunlink Health Systems Inc vs. its Competitors, Q3 2025

Revenue growth, year on year

Sunlink Health Systems Inc -2.1 %
Competitors combined +2.4 %

Net margin

Sunlink Health Systems Inc -9.2 %
Competitors combined +8.4 %

Revenue run-rate vs trailing 12 months

Sunlink Health Systems Inc -8.0 %
Competitors combined -4.5 %

TTM net margin

Sunlink Health Systems Inc +5.4 %
Competitors combined +8.5 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Sunlink Health Systems Inc and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Sunlink Health Systems Inc $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Similar Growth & Profitability (6) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Sunlink Health Systems Inc's competitor groups requires a Commercial License.

For context: the Healthcare Facilities industry grew revenue 14.7% year over year, combined, vs -2.1% for Sunlink Health Systems Inc. Sunlink Health Systems Inc's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.

Sunlink Health Systems Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Sunlink Health Systems Inc Yes No No No
Competitors combined (10) 70% 80% 80% 0%
Similar Growth & Profitability (8) 0.00 % (0 of 8) 12.50 % (1 of 8) 0.00 % (0 of 8) 37.50 % (3 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2025

0%market share
  • Sunlink Health Systems Inc0.0%
  • Competitors combined100.0%

Share of combined quarterly revenue of Sunlink Health Systems Inc and its 10 tracked competitors.

See Sunlink Health Systems Inc's full market share breakdown »

SSY Stock Performance relative to its Competitors

SSY Competitors (weighted) Percent change over the selected range

Sunlink Health Systems Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
33.3%beat U.S.A. 500
Competitors Combined
(3 of 9)
20%beat U.S.A. 500
Similar Growth & Profitability
(1 of 5)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Sunlink Health Systems Inc 25.40 % Outperformed
Competitors combined (9) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (5) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Sunlink Health Systems Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

SSY Stock Performance relative to Similar Growth & Profitability Competitors

SSY Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

5 Best-Performing Tracked Competitors, Trailing 12 Months

#CompetitorTTM Share Price Returnvs U.S.A. 500
1 Davita Inc 282.9% Outperformed
2 Tenet Healthcare Corp 282.9% Outperformed
3 Acadia Healthcare Company Inc 282.9% Outperformed
4 Select Medical Holdings Corp 282.9% Outperformed
5 Hca Healthcare Inc 282.9% Outperformed
Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Sunlink Health Systems Inc's best-performing tracked competitors requires a Commercial License.

Source: CSIMarket API, trailing 12 months.

Sunlink Health Systems Inc's Comment on Competition and Industry Peers

The company operates in a competitive environment alongside national pharmacy chains with extensive resources and distribution networks, as well as local pharmacies with established community reputations. Competition factors include location, convenience, service quality, participation in pharmacy reimbursement and benefit plans, and overall reputation. The company focuses on providing personal service through local staff familiar to the community to differentiate itself from larger chains. SHS Technology competes with firms offering IT hosting, computer hardware, IT software implementation, and IT consulting services. SHS Technology does not sell hardware or software. Some competitors have larger staffs, greater resources, and may receive subsidies from hardware or software vendors or related businesses. The IT services market experiences intense price competition, and some potential clients continue to use legacy IT systems that are challenging to transition to systems supported by SHS Technology.

Publicly Traded Peers of Sunlink Health Systems Inc

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Sunlink Health Systems Inc 7.85 31.77 1.73 476
Hca Healthcare Inc 98,049.66 76,388.00 7,814.00 320,000
Tenet Healthcare Corp 21,656.83 21,812.00 3,174.00 99,000
Davita Inc 11,769.00 14,009.65 1,189.54 78,000
Universal Health Services Inc 10,632.83 18,114.49 1,550.21 101,500
Acadia Healthcare Company Inc 2,535.87 3,371.07 -1,096.52 25,000
SUBTOTAL 148,538.75 158,408.88 13,358.98 698,576
5 more competitors available

Sign in to see all competitors of Sunlink Health Systems Inc .

Sources: Sunlink Health Systems Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Sunlink Health Systems Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Sunlink Health Systems Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
SHS Technology Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Sunlink Health Systems Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Sunlink Health Systems Inc's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Hca Healthcare Inc American Group 34.90 % Atlantic Group 32.91 % National Group 27.95 %
Tenet Healthcare Corp Hospital Operations 75.34 % Ambulatory Care 24.66 % -
Davita Inc U. S. Dialysis And Related Lab Services 84.42 % External Sources 84.24 % Other with Intersegment 15.66 %
Universal Health Services Inc Acute Care Hospital Services 56.27 % Behavioral Health Services 43.66 % Corporate and Unallocated 0.06 %
Acadia Healthcare Company Inc United States Facilities 100.00 % - -

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

3 more Peers available

Sign in to see all peers for Sunlink Health Systems Inc .

Sunlink Health Systems Inc's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Sunlink Health Systems Inc 8 66,752 3,624
Hca Healthcare Inc 98,050 238,713 24,419
Tenet Healthcare Corp 21,657 220,323 32,061
Davita Inc 11,769 179,611 15,250
Universal Health Services Inc 10,633 178,468 15,273
Acadia Healthcare Company Inc 2,536 134,843 -43,861
PEERS TOTAL 148,531 226,869 19,134
5 more Peers available

Sign in to see all peers for Sunlink Health Systems Inc .

Sunlink Health Systems Inc's Position in Industry Market Structure

Market-capitalization share and concentration across all 48 companies in Sunlink Health Systems Inc's industry classification, broader than the peer set above. Market cap in millions of $.

Sunlink Health Systems Inc ranks #0 of 48 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,749, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).

Rank Company Market Cap Industry Share
1 Hca Healthcare Inc 100,440 38.81 %
2 Tenet Healthcare Corp 22,258 8.60 %
3 Fresenius Medical Care Ag 13,424 5.19 %
4 Brightspring Health Services Inc 12,539 4.84 %
5 Encompass Health Corporation 1,234 5.2%
6 Davita Inc 1,234 5.2%
7 Universal Health Services Inc 1,234 5.2%
8 Ensign Group Inc 1,234 5.2%
9 Pacs Group Inc 1,234 5.2%
10 Chemed Corporation 1,234 5.2%
0 Sunlink Health Systems Inc 8 0.00 %
Full Industry Market Structure

Market cap and industry share for the rest of Sunlink Health Systems Inc's industry peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2025-08-14.

Sunlink Health Systems Inc's Profitability & Cost Structure

Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Healthcare Facilities industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (77 companies).
Metric Company Industry Difference
Gross Margin 44.27 % 52.28 % (avg) -8.0 pp
Operating Margin -11.22 % industry median -17.3 pp
EBITDA Margin -4.30 % 3.22 % (avg) -7.5 pp
Capital Intensity (Capex / Revenue) 2.95 % 4.01 % (avg) -1.1 pp

Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.

Sunlink Health Systems Inc's Valuation vs Competitive Position

Valuation multiples vs the Healthcare Facilities industry average (77 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.
Metric Company Industry Average Difference
P/E 3.3x 23.5x -20.2x
EV / EBITDA - 15.7x -
P/B 0.5x 3.3x -2.8x
Return on Equity 11.72 % industry aggregate -17.99 %
Return on Invested Capital -12.07 % 4.91 % (avg) -16.98 %

Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.

Sunlink Health Systems Inc's Multi-Year Financial Trajectory

Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.
Metric 201520202021202220232024
Revenue Growth -44.85 %--12.37 %-12.96 %-20.29 %
Operating Margin 0.06 %-3.03 %5.42 %-9.07 %-11.70 %
Return on Invested Capital 0.08 %-5.88 %12.74 %-11.08 %-13.02 %
P/E --3.2x--3.4x

Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.

Sunlink Health Systems Inc's Strategic Group Map

Every company in Sunlink Health Systems Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Sunlink Health Systems Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.

Revenue Growth (TTM, %)Operating Margin (%)BKDCCELQHCCQAHCOALRTDOCAIRSCDIFSunlink Health Systems Inc

Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.

Sunlink Health Systems Inc's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.
Force Assessment Basis
Competitive Rivalry Moderate Industry HHI of 1,749 (see Industry Market Structure & Concentration above)
Barriers to Entry Lower than typical for the industry Capital intensity (capex / revenue) of 2.95 % vs industry average 4.01 % (see Profitability & Cost Structure above)
Supplier Power Not covered on this page See Sunlink Health Systems Inc's dedicated suppliers page for concentration and dependency data
Buyer Power Not covered on this page See Sunlink Health Systems Inc's dedicated customers page for concentration and dependency data
Threat of Substitutes - No systematic data source for cross-product substitution exists in this system; not estimated

Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.

Sunlink Health Systems Inc's Industry Attractiveness & Competitive Strength

A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.

High Strength
Medium Strength
Low Strength
High Attractiveness
Invest / Grow
Invest / Grow
Selective
Medium Attractiveness
Invest / Grow
Selective
Harvest
Low Attractiveness
Selective
Harvest
Harvest / Divest Sunlink Health Systems Inc

Sunlink Health Systems Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.

Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.

Sunlink Health Systems Inc's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

  • Outperforming the U.S.A. 500 over the trailing 12 months.

Weaknesses

  • Operating margin 17.3 points below the industry median.
  • Return on equity 18.0 points below the industry aggregate.
  • Latest-quarter revenue run-rate is decelerating (-8.0% annualized vs trailing 12 months).

Opportunities

No rule matched.

Threats

  • Industry dominated by Hca Healthcare Inc , holding 38.81 % of industry market cap.
  • Tracked peer group's revenue run-rate is broadly decelerating (-4.5% annualized).

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Sunlink Health Systems Inc's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Sunlink Health Systems Inc 2.00 3.93 - 1.68
Hca Healthcare Inc 0.06 0.90 - 1.27
Tenet Healthcare Corp 0.53 1.54 3.16 0.72
Davita Inc 0.23 1.38 - 0.80
Universal Health Services Inc 0.04 1.07 0.72 1.16
Acadia Healthcare Company Inc 0.26 1.50 0.95 0.57
5 more Peers available

Sign in to see all peers for Sunlink Health Systems Inc .

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Sunlink Health Systems Inc's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Sunlink Health Systems Inc Q1 2025-2.1 %-7.9 %--
Hca Healthcare Inc Q1 2026+4.3 %-2.1 %+1.8 %-14.1 %
Tenet Healthcare CorpQ2 2026+6.8 %+4.8 %+100.2 %+15.3 %
Davita Inc Q2 2026+5.2 %+4.1 %+24.7 %+24.8 %
Universal Health Services Inc Q2 2026+8.3 %+3.2 %+0.5 %+1.6 %
Acadia Healthcare Company Inc Q1 2026+7.6 %+0.9 %-50.8 %-
PEERS TOTAL+3.9 %+0.1 %+9.5 %+48.7 %
5 more Peers available

Sign in to see all peers for Sunlink Health Systems Inc .

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Sunlink Health Systems Inc's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Sunlink Health Systems Inc Q1 2025-2.4 %-8.3 %-27.2 %+10.9 %
Hca Healthcare Inc Q1 2026--+12.9 %-24.8 %
Tenet Healthcare CorpQ2 2026+14.4 %+17.6 %-13.0 %-6.7 %
Davita Inc Q2 2026--+40.2 %+66.5 %
Universal Health Services Inc Q2 2026---14.4 %+4.8 %
Acadia Healthcare Company Inc Q1 2026---56.2 %-17.8 %
5 more Peers available

Sign in to see all peers for Sunlink Health Systems Inc .

Sunlink Health Systems Inc's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Sunlink Health Systems Inc 9.13%11.65%11.72%10.4611.58
Hca Healthcare Inc 12.94%18.54%-7.09-
Tenet Healthcare Corp10.49%9.98%50.64%8.471.76
Davita Inc 6.77%6.92%-5.79-
Universal Health Services Inc 9.92%12.43%20.89%6.75-
Acadia Healthcare Company Inc ---7.70-
5 more Peers available

Sign in to see all peers for Sunlink Health Systems Inc .

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Sunlink Health Systems Inc's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Sunlink Health Systems Inc 3.850.25-1.260.59
Hca Healthcare Inc 15.031.280.52--
Tenet Healthcare Corp7.090.990.05-3.30
Davita Inc 10.860.840.18--
Universal Health Services Inc 7.270.590.12343.181.40
Acadia Healthcare Company Inc -0.75-37.721.29
PEERS AVERAGE11.120.94-10.15
5 more Peers available

Sign in to see all peers for Sunlink Health Systems Inc .

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.